Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine

Blood

Volumn 115, Issue 10, 2010, Pages 1893-1896

  Sigal, Darren S ^a   Sharpe, Robert ^a   Burian, Carol ^b   Saven, Alan ^a  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS GREEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; ERADICATION THERAPY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; LONG TERM CARE; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; TISSUE SECTION; TREATMENT RESPONSE;

EID: 77950398474     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-251645     Document Type: Article

References (19)

1. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609-630.
2. Schrek R, Donnelly WJ. "Hairy" cells in blood in lymphoreticular neoplastic disease and "flagellated" cells of normal lymph nodes. Blood. 1966; 27(2):199-211.
3. Jansen J, Hermans J. Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer. 1981;47(8):2066-2076.
4. Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol. 1995;13(4):974-982.
5. Else M, Ruchlemer R, Osuji N, et al. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer. 2005;104(11):2442-2448. (Pubitemid 41691566)
6. Saven A, Burian C, Koziol JA, et al. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood. 1998;92(6):1918-1926. (Pubitemid 28446680)
7. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med. 1990;322(16):1117-1121.
8. Goodman GR, Burian C, Koziol JA, et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol. 2003;21(5):891-896. (Pubitemid 46606450)
9. Chadha P, Rademaker AW, Mendiratta P, et al. Treatment of hairy cell leukemia with 2-chlorode-oxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005;106(1):241-246. (Pubitemid 40967199)
10. Ellison DJ, Sharpe RW, Robbins BA, et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood. 1994;84(12):4310-4315. (Pubitemid 24371937)
11. Hakimian D, Tallman MS, Kiley C, Peterson L. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood. 1993;82(6):1798-1802.
12. Wheaton S, Tallman MS, Hakimian D, Peterson L. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood. 1996;87(4):1556-1560. (Pubitemid 26056921)
13. Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet. 1992;340(8825):952-956.
14. Robbins BA, Ellison DJ, Spinosa JC, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood. 1993;82(4):1277-1287.
15. Sausville JE, Salloum RG, Sorbara L, et al. Minimal residual disease detection in hairy cell leukemia: comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am J Clin Pathol. 2003;119(2):213-217. (Pubitemid 37047876)
16. Arons E, Margulies I, Sorbara L, et al. Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction. Clin Cancer Res. 2006;12(9):2804-2811. (Pubitemid 43752120)
17. MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996;14(4):1282-1290.
18. Tallman MS, Hakimian D, Kopecky KJ, et al. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2′-deoxycoformycin and prediction of early relapse. Clin Cancer Res. 1999;5(7):1665-1670. (Pubitemid 29334443)
19. Ravandi F, Jorgensen JL, O'Brien S, et al. Eradication of minimal residual disease in hairy cell leukemia. Blood. 2006;107(12):4658-4662. (Pubitemid 43882611)